Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gemcitabine; Paclitaxel
- Indications Germ cell and embryonal neoplasms; Ovarian cancer; Testicular cancer
- Focus Therapeutic Use
- 02 Feb 2010 Actual end date (Jul 2002) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2010 Biomarkers information updated